Please provide your email address to receive an email when new articles are posted on . Four chemotherapy cycles with bleomycin appeared too toxic for elderly patients with early-stage Hodgkin ...

Bleomycin pulmonary toxicity (BPT) has been well described in Hodgkin's lymphoma (HL) patients treated with bleomycin-containing chemotherapy regimens. The influence of this pulmonary complication, ...

February 21, 2011 (Orlando, Florida) — In patients taking bleomycin for germ cell tumors, the use of lung function testing to monitor for drug-induced pneumonitis is controversial. A new study ...

A variety of cancers are treated with the anti-tumor agent bleomycin, though its disease-fighting properties remain poorly understood. In a new study, lead author Basab Roy—a researcher at Arizona ...

A response-adapted approach to the treatment of patients with advanced Hodgkin's lymphoma de-escalates treatment after an early negative PET scan and intensifies treatment in those with a PET-positive ...

Shedding light on the disease-fighting properties of Bleomycin, used in medications to treat a variety of cancers, a study by an Indian-origin scientist has revealed that the anti-tumour agent has the ...

Bleomycin is an anti – cancer agent, used for the treatment of skin, oral cavity, head and neck cancer. The therapeutic efficacy of Bacillus calmette-guerin substrain connaught live antigen can be ...

A 48-year-old white man presented with a 4-week history of itchy lesions on the skin of his upper back and shoulders. The patient’s medical history included ulcerative colitis and a seizure disorder.